Crispr Therapeutics AG Price to FCF Ratio 2016–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Crispr Therapeutics AG (CRSP): market cap divided by trailing twelve-month free cash flow. As of September 30, 2022 it is 11.15.

From: 03/31/2017To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Crispr Therapeutics AG Price to FCF Ratio — FAQ

Crispr Therapeutics AG (CRSP) price to fcf ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRSP's price to fcf ratio history?

The chart and table above show Crispr Therapeutics AG's price to fcf ratio by year and by quarter, including the growth rate.